Mount Sinai Microbiologist Selected as Revson Senior Fellow in Biomedical Science
Jessica Sook Yuin Ho, PhD, a postdoctoral fellow in microbiology at the Icahn School of Medicine at Mount Sinai, has been selected as a Charles H. Revson Senior Fellow in Biomedical Science by the Charles H. Revson Foundation.
Jessica Sook Yuin Ho, PhD, a postdoctoral fellow in microbiology at the Icahn School of Medicine at Mount Sinai, has been selected as a Charles H. Revson Senior Fellow in Biomedical Science by the Charles H. Revson Foundation. The two-year fellowship is awarded annually to eight exceptionally talented New York City scientists entering their third or fourth year of postdoctoral research.
Intended to help address the need for funding during the critical third and fourth years of training when postdoctoral fellows are finishing their initial projects and establishing themselves as independent researchers, the fellowship attracts applications from dozens of highly qualified candidates from 13 top medical and research institutions. Only a select few are chosen.
Dr. Sook Yuin Ho works in the Marazzi Laboratory in the Department of Microbiology at Icahn Mount Sinai. Her research focuses on a novel viral protein and its role in pathogenesis. She wrote her fellowship application based on a paper she published in Cell in 2020, which focused on the presence of human-chimeric proteins/genes that are generated during influenza A infection. Essentially, she and her colleagues assert that these proteins are not generated by chance during infection, but are actually a means for the virus to explore its genetic potential to encode new genes. Additionally, they posit that these proteins could be suitable targets for future therapeutic or vaccine design for influenza A virus. Dr. Sook Yuin Ho is interested in further characterizing the functions and roles of these proteins in infected cells.
“Most of our high-risk projects depend on the support of private foundations that understand the need to promote transformative discoveries,” said Ivan Marazzi, PhD, Associate Professor of Microbiology at Icahn Mount Sinai. “We are grateful to the Revson Foundation for their recognition of our work and for their support of Dr. Sook Yuin Ho’s important scientific endeavors.”
About the Mount Sinai Health System
The Mount Sinai Health System is New York City's largest academic medical system, encompassing eight hospitals, a leading medical school, and a vast network of ambulatory practices throughout the greater New York region. Mount Sinai advances medicine and health through unrivaled education and translational research and discovery to deliver care that is the safest, highest-quality, most accessible and equitable, and the best value of any health system in the nation. The Health System includes approximately 7,300 primary and specialty care physicians; 13 joint-venture ambulatory surgery centers; more than 415 ambulatory practices throughout the five boroughs of New York City, Westchester, Long Island, and Florida; and more than 30 affiliated community health centers. The Mount Sinai Hospital is ranked on U.S. News & World Report's "Honor Roll" of the top 20 U.S. hospitals and is top in the nation by specialty: No. 1 in Geriatrics and top 20 in Cardiology/Heart Surgery, Diabetes/Endocrinology, Gastroenterology/GI Surgery, Neurology/Neurosurgery, Orthopedics, Pulmonology/Lung Surgery, Rehabilitation, and Urology. New York Eye and Ear Infirmary of Mount Sinai is ranked No. 12 in Ophthalmology. Mount Sinai Kravis Children's Hospital is ranked in U.S. News & World Report’s “Best Children’s Hospitals” among the country’s best in four out of 10 pediatric specialties. The Icahn School of Medicine is one of three medical schools that have earned distinction by multiple indicators: ranked in the top 20 by U.S. News & World Report's "Best Medical Schools," aligned with a U.S. News & World Report "Honor Roll" Hospital, and No. 14 in the nation for National Institutes of Health funding. Newsweek’s “The World’s Best Smart Hospitals” ranks The Mount Sinai Hospital as No. 1 in New York and in the top five globally, and Mount Sinai Morningside in the top 20 globally.